Drug recall D-0150-2017
Product
LEVOXYL(R) (levothyroxine sodium tablets, USP), 200 mcg, 100 count bottles, Rx only, Manufactured and Distributed by: King Pharmaceuticals, Inc., Bristol, TN 37620, NDC 60793-860-01
Reason for recall
Superpotent
Lots and codes
16H21, Exp. 08/2017
Recall details
- Recalling firm
- Pfizer Inc., New York, NY
- Quantity
- 2,666 bottles
- Distribution
- Nationwide
- Type
- Voluntary: Firm initiated
- Recall initiated
- November 7, 2016
- Terminated
- May 1, 2020
Related products
- Levoxyl – drug information
- NDC 60793-860 Levoxyl · Levothyroxine Sodium 200 ug/1 · Pfizer Laboratories Div Pfizer Inc
- NDC 60793-859 Levoxyl · Levothyroxine Sodium 175 ug/1 · Pfizer Laboratories Div Pfizer Inc
- NDC 60793-858 Levoxyl · Levothyroxine Sodium 150 ug/1 · Pfizer Laboratories Div Pfizer Inc
- NDC 60793-853 Levoxyl · Levothyroxine Sodium 88 ug/1 · Pfizer Laboratories Div Pfizer Inc
- NDC 60793-855 Levoxyl · Levothyroxine Sodium 112 ug/1 · Pfizer Laboratories Div Pfizer Inc
- NDC 60793-852 Levoxyl · Levothyroxine Sodium 75 ug/1 · Pfizer Laboratories Div Pfizer Inc
- NDC 60793-850 Levoxyl · Levothyroxine Sodium 25 ug/1 · Pfizer Laboratories Div Pfizer Inc
- NDC 60793-851 Levoxyl · Levothyroxine Sodium 50 ug/1 · Pfizer Laboratories Div Pfizer Inc
- NDC 60793-856 Levoxyl · Levothyroxine Sodium 125 ug/1 · Pfizer Laboratories Div Pfizer Inc
- NDC 60793-854 Levoxyl · Levothyroxine Sodium 100 ug/1 · Pfizer Laboratories Div Pfizer Inc
- NDC 60793-857 Levoxyl · Levothyroxine Sodium 137 ug/1 · Pfizer Laboratories Div Pfizer Inc